GEC-ESTRO APBI classification as a decision-making tool for the management of 2nd ipsilateral breast tumor event
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10549-019-05221-z.pdf
Reference25 articles.
1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al (2015) Reprint of: cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer 51:1201–1202
2. Bleyer A, Welch HG (2013) Effect of three decades of screening mammography on breast-cancer incidence: editorial comment. Obstet Gynecol Surv 68:440–442
3. Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomized trial comparing total for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241
4. Kurtz JM, Amalric R, Brandone H et al (1988) Results of wide excision for mammary recurrence after breast-conserving therapy. Cancer 61:1969–1972
5. Maulard C, Housset M, Brunel P et al (1995) Use of perioperative or split-course interstitial brachytherapy techniques for salvage irradiation of isolated local recurrences after conservative management of breast cancer. Am J Clin Oncol 18:348–352
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Partial Breast Irradiation;Hypofractionated and Stereotactic Radiation Therapy;2024
2. Second Conservative Treatment for Local Recurrence Breast Cancer: A GEC-ESTRO Oncological Outcome and Prognostic Factor Analysis;International Journal of Radiation Oncology*Biology*Physics;2023-12
3. Second Breast Conserving Therapy: Who, What, When, and How?;International Journal of Radiation Oncology*Biology*Physics;2023-12
4. Can breast cancer be reirradiated?;Revista de Senología y Patología Mamaria;2023-10
5. Tolerance and Oncological Outcomes of In-Field Reirradiation for Locally Recurrent Breast Cancer: A Long-Term Single-Center Experience;Cancers;2023-09-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3